Drugs / RTS,S/AS02D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00197067 | Mar 2004 → Apr 2005 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTS,S/AS02D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00197067 ↗ |
| Route | Intramuscular | “receive RTS,S/AS02D (0.5 ml dose) or RTS,S/AS02A (0.25 ml dose) intramuscularly” NCT00197067 ↗ |